Bioavailability and Dosing of a Monosaccharide Supplement in Adults
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
We are developing an oral supplement of carbohydrates to be added to infant formulas in order to improve brain development, immune function, and overall health of infants and children. After a careful review of what is known about these sugars, there is very little information regarding their use in infants and children, although there is some information in adults and animals.
Many of these sugars have been used in a glyco-nutritional supplement in adults and children, with minimal or no reported side effects.
We are developing a custom blend of important individual sugars, and need information regarding their dosing and blood concentrations following oral intake of the carbohydrate supplement. Timed blood samples following the carbohydrate supplement will provide us with a better understanding of the most effective dose and the metabolism of these sugars in adults. This will give us the preliminary information we need for developing an oral supplement of special sugars that can be added to infant formulas to help improve brain development and immune function in infants and children.
| Condition |
|---|
|
Healthy Males |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | Bioavailability and Dosing of an Oral Monosaccharide Supplement in Adults and Effects on Resting Brain Activity |
Eligibility| Ages Eligible for Study: | 18 Years to 28 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Healthy Caucasian Males
Inclusion Criteria:
- Caucasian (non-hispanic)
- Male
- Age 18-28
- Regularly eat breakfast
- Healthy
- BMI within normal limits (18.5 - 24.9)
- English speaking
Exclusion Criteria:
- History of smoking, more than occasional alcohol use, or drug use.
- Chronic medical diagnosis
- Medications that may interfere with the study
Contacts and Locations| United States, Arkansas | |
| Arkansas Children's Nutrition Center | |
| Little Rock, Arkansas, United States, 72202 | |
More Information
No publications provided
| Responsible Party: | Joanne S. Szabo, M.D., University of Arkansas for Medical Sciences |
| ClinicalTrials.gov Identifier: | NCT00782392 History of Changes |
| Other Study ID Numbers: | 45092 |
| Study First Received: | October 29, 2008 |
| Last Updated: | May 16, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Arkansas Children's Hospital Research Institute:
|
Nutrition Infant Formula |
ClinicalTrials.gov processed this record on May 19, 2013